Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Commentary on: "Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss", by G. R. W. Moore, et al. in J Neurol (2008) 255: DOI 10.1007/s00415-008-0002-z.
Multiple sclerosis relapse mimicking a transient ischemic attack.
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
The level of viral infection of antigen-presenting cells is critical for the development of TMEV-induced demyelinating disease.
Dual role of microglia in health and disease: pushing the balance toward repair.
A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain.
Secondary progressive NMO, or concomitant NMO and a primary neurodegenerative disorder?
Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.
Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study.
Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy.
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a.
Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study.
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Interferon treatment of multiple sclerosis.
Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Multiple sclerosis starting before the age of 18 years: the Brazilian experience.
Sleep Loss as a Factor to Induce Cellular and Molecular Inflammatory Variations.
Vitamin d as a potential therapy in amyotrophic lateral sclerosis.
Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.
Composite end points to assess delay of disability progression by MS treatments.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Long-term epidemiology of multiple sclerosis in the Northern Seville District.
Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder.
A case of multiple sclerosis with bilateral intermediate uveitis.
Metabolomics of Neurodegenerative Diseases.
Pages
« first
‹ previous
…
642
643
644
645
646
647
648
649
650
…
next ›
last »